SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

SALVADORI, Severo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.334
EU - Europa 4.390
AS - Asia 3.330
SA - Sud America 79
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 5
OC - Oceania 5
Totale 26.152
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.280
CN - Cina 1.681
UA - Ucraina 1.253
DE - Germania 947
TR - Turchia 827
SG - Singapore 734
IT - Italia 639
GB - Regno Unito 595
FI - Finlandia 361
SE - Svezia 314
BE - Belgio 77
BR - Brasile 62
CA - Canada 54
FR - Francia 52
PL - Polonia 35
NL - Olanda 29
IR - Iran 20
IN - India 19
RU - Federazione Russa 19
LT - Lituania 18
CZ - Repubblica Ceca 14
ID - Indonesia 10
HK - Hong Kong 8
CO - Colombia 7
KR - Corea 7
RO - Romania 7
AT - Austria 6
CL - Cile 6
EU - Europa 5
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
HR - Croazia 3
IE - Irlanda 3
NZ - Nuova Zelanda 3
PH - Filippine 3
UZ - Uzbekistan 3
VN - Vietnam 3
AU - Australia 2
BG - Bulgaria 2
DK - Danimarca 2
ES - Italia 2
GR - Grecia 2
JP - Giappone 2
KE - Kenya 2
NO - Norvegia 2
NP - Nepal 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
DZ - Algeria 1
EC - Ecuador 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MM - Myanmar 1
NG - Nigeria 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 26.152
Salva come PNG Salva come JPEG
Città #
Fairfield 2.354
Woodbridge 2.335
Houston 1.563
Jacksonville 1.424
Ann Arbor 1.246
Ashburn 1.164
Chandler 1.099
Seattle 893
Wilmington 841
Cambridge 786
Santa Clara 771
Singapore 514
Izmir 436
Nanjing 411
Beijing 325
Princeton 275
San Diego 230
Boardman 196
Dearborn 196
Milan 176
Ferrara 148
Munich 120
Nanchang 118
Shenyang 116
Helsinki 101
Shanghai 100
Los Angeles 91
Addison 89
New York 88
Falls Church 81
San Mateo 75
Brussels 72
Hebei 71
Falkenstein 66
Auburn Hills 65
Jiaxing 63
Bremen 62
Jinan 61
Changsha 58
Tianjin 56
Mountain View 49
Kunming 47
London 42
Redwood City 41
Zhengzhou 39
Washington 38
Philadelphia 37
Ningbo 35
Norwalk 35
Warsaw 34
Tappahannock 24
Guangzhou 23
Toronto 23
Des Moines 22
Mcallen 22
Orange 21
Indiana 19
Bologna 17
Montréal 17
Hefei 15
Frankfurt am Main 14
Taizhou 14
Augusta 13
Leawood 12
Redmond 12
Verona 12
Lanzhou 11
Ardabil 10
Düsseldorf 10
Jakarta 10
Ottawa 9
Prescot 9
Hounslow 8
Kilburn 8
Padova 8
Hong Kong 7
Medellín 7
Changchun 6
Chicago 6
Florence 6
Hangzhou 6
Olomouc 6
Bari 5
Brno 5
Chiswick 5
Council Bluffs 5
Haikou 5
New Bedfont 5
Osasco 5
San Francisco 5
Walnut 5
Brescia 4
Clifton 4
Ferrara di Monte Baldo 4
Fuzhou 4
Yellow Springs 4
Amsterdam 3
Dublin 3
Innsbruck 3
Islington 3
Totale 19.817
Salva come PNG Salva come JPEG
Nome #
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 239
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 221
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 179
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 176
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 173
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 169
A CYCLIC PEPTIDE T ANALOGUE WITH HIGH CHEMOTACTIC ACTIVITY 160
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 155
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 151
Physicochemical stability of cabazitaxel and docetaxel solutions 151
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 148
A new selective antagonist of the nociceptin receptor 147
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 147
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 146
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 144
Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline‐3‐carboxylic acid at position 2 142
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic 141
Pharmacological characterization of nociceptin receptor: an in vitro study 139
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 138
A new ligand for the urotensin II receptor 138
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 138
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 137
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 136
Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic. 136
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 134
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 134
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 132
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 130
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 130
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 130
null 130
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 129
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 129
Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects 129
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 127
2-Bromoamides as Synthons for Pseudopeptides Containing Aminodicarboxy Units 126
Dermorphin inhibits spinal nociceptive flexion reflex in humans 126
Stimulatory effect of dermorphin, a new synthetic potent opiate-like peptide, on human growth hormone secretion 126
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 125
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 125
Synthesis and opioid activity of partial retro‐inverso analogs of dermorphin 125
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 124
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 124
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 124
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 123
null 121
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 121
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model 121
Pharmacological characterization of tachykinin tetrabranched derivatives 121
Responses of plasma renin activity, aldosterone, adrenocorticotropin, and cortisol to dermorphin, a new synthetic potent opiate-like peptide, in man 120
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 120
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 120
Cholinergic mediation in dermorphin-induced growth hormone secretion in man 120
New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophores 119
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 119
Structure-activity study at positions 3 and 4 of human neuropeptide S. 119
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 118
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore 118
Critical role for prokineticin 2 in CNS autoimmunity 118
Prolactin-Releasing Activity of Dermorphin, a New Synthetic Potent Opiate-Like Peptide, in Normal Human Subjects 118
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 118
2-Aminoamides and Pseudopeptides Carrying an Amino Group Common to two Residues 118
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 117
Design of d-opioid peptide antagonists for emerging drug applications 117
Effect of dermorphin on behavior and hippocampal electrical activity in rabbits 115
Synthesis and antimicrobial activity of dermaseptin S1 analogues 115
Synthesis and Pharmacological Activity of Partially Modified Retro-Inverso Dermorphin Tetrapeptides 115
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 115
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 114
Neuropeptide S receptor ligands: a patent review (2005-2016) 114
Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma 114
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 114
Opioid diketopiperazines: Synthesis and activity of a prototypic class of opioid antagonists 113
The SH3 domain of nebulin binds selectively to type II peptides: theoretical prediction and experimental validation 113
Structure–activity relationships of cyclic and linear peptide T analogues 113
Role of benzimidazole (Bid) in the d-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH2-Bid (UFP-502) 113
Opioid receptor selectivity alteration by single residue replacement: Synthesis and activity profile of [Dmt]deltorphin B 112
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 112
Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors 112
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A 111
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 111
Single Diastereomeric Desaminotyrosylalanyl Tetra- and Heptapeptides with Opioid Antagonistic Activity 111
Symmetry-based inhibitors of HIV-1 protease. Design, synthesis and preliminary structure-activity studies of acylated 2,3-diamino-1-hydroxypropanes and 2,4 diamino-1-hydroxybutanes 111
Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands 110
Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. 110
null 110
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. 110
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 110
HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure 110
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 109
Synthetic Approach to non-Isosteric Peptidomimetics Related to Human Endothelin 108
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 108
Urodynamic effects of intravesical nociceptin/orphanin FQ in neurogenic detrusor overactivity: A randomized, placebo-controlled, double-blind study 108
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 108
Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds 107
Synthesis and biological activity of carboxyl terminally extended dermorphins 107
Assessment of substitution in the second pharmacophore of Dmt-Tic analogues 107
Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex 107
Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues 106
null 106
Totale 12.685
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.020
Totale 126.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.016 0 0 0 0 0 0 0 634 455 574 226 127
2020/20213.418 305 343 144 468 134 366 112 407 84 416 469 170
2021/20222.981 126 290 230 211 227 133 136 170 113 227 223 895
2022/20232.728 296 96 90 335 463 379 148 270 387 16 143 105
2023/20241.289 150 181 94 32 103 233 51 82 17 22 32 292
2024/20252.194 140 106 409 141 635 457 156 150 0 0 0 0
Totale 26.411